Comparative Effectiveness of Different Neuroprotectants Among Patients With Acute Ischemic Stroke in Clinical Practice

Trial Profile

Comparative Effectiveness of Different Neuroprotectants Among Patients With Acute Ischemic Stroke in Clinical Practice

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Brain extract (Primary) ; Butylphthalide (Primary) ; Citicoline (Primary) ; Edaravone (Primary) ; Piracetam (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms CER
  • Most Recent Events

    • 23 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top